EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial

Telehealth-Plus-mHealth-Intervention für junge Erwachsene mit Cannabisgebrauchsstörung: Protokoll für eine pilotierte randomisierte kontrollierte Studie

Lydia A Shrier iD, Avery Palmer iD, Sarah Parker, Joe Kossowsky iD, Sabra L Katz-Wise iD, Pamela J Burke iD, Carly E Milliren iD, Sion Kim Harris iD

JMIR Research Protocols · 2026-08-20 · 15 · e105908-e105908

DOI: 10.2196/105908 ↗

Auf einen Blick

Geplant ist eine 2-armige Pilot-RCT zu MOMENT-V bei 18- bis 26-Jährigen mit Cannabisgebrauchsstörung in der Primärversorgung. Untersucht werden Interventions- und Studiendurchführbarkeit.

Fragestellung

Ist MOMENT-V gegenüber verstärkter üblicher Versorgung bei jungen Erwachsenen mit Cannabisgebrauchsstörung machbar und akzeptabel?

Methode

Parallel angelegte, 2-armige Pilot-RCT bei 18- bis 26-Jährigen aus Primärversorgungskliniken; 1:1-Randomisierung zu MOMENT-V oder EUC; Erhebungen zu mehreren Zeitpunkten.

Ergebnisse

Geplante Stichprobe: N=60. Primäre Endpunkte sind Completion, EMI-Engagement und Akzeptanz sowie Screening-, Eignungs-, Einschluss- und Retentionsraten.

Einschränkungen

Protokoll; Ergebnisse liegen noch nicht vor.

Schlussfolgerung der Autor:innen

Die Studie soll Daten zur MOMENT-V-Digitalintervention und zur Durchführbarkeit der Studie für eine spätere Wirksamkeitsstudie liefern.

Kernaussagen

  • MOMENT-V kombiniert Telehealth-MET mit mobiler EMI.
  • Vergleich ist enhanced usual care (EUC).
  • Primär: Machbarkeit von Intervention und Studie.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-08-20. Written by Lydia A Shrier and 7 co-authors. Institution: Department of Pediatrics, Harvard Medical School, Boston, MA, United States. Major MEDLINE topics: Marijuana Abuse. Cited 1 times so far (Crossref); 88 references. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

More than 5 million young adults in the United States meet criteria for cannabis use disorder (CUD), placing them at risk for adverse physical, psychiatric, and social outcomes. Most individuals with CUD do not receive treatment due to numerous barriers, including motivation, stigma, limited availability and accessibility of developmentally appropriate services, and competing demands for time and finances. A novel digital health intervention, Momentary Self-Monitoring and Feedback + Motivational Enhancement Therapy—Virtual (MOMENT-V), was developed and combines telehealth motivational enhancement therapy with mobile health ecological momentary intervention (EMI) to provide a fully remote brief intervention for CUD among young adults.

Objective

We describe the protocol for a parallel, 2-arm, pilot randomized controlled trial of MOMENT-V vs enhanced usual care (EUC) to evaluate intervention and trial feasibility in young adults with CUD recruited from primary care clinics.

Methods

We are inviting primary care patients, aged 18 to 26 years, to self-screen through clinic posters with QR codes, invitations from clinicians, and patient portal messages. Eligible patients (eg, Cannabis Use Disorder Identification Test-Revised score ≥12, cannabis use ≥ 3 days/week, and smartphone ownership; N=60) will be randomly assigned 1:1 to receive MOMENT-V or EUC. MOMENT-V will include 2 weekly sessions of motivational enhancement therapy via telehealth, then 2 weeks of mobile health EMI—mobile self-monitoring with messages following reports of personal triggers for use. EUC will include a brief meeting with a counselor to review cannabis use problems and provide substance use and mental health resources. Participants will be assessed via surveys and a timeline followback calendar interview at baseline, 3 weeks, 3 months, and 6 months, and by an interview at 6 months. Primary outcomes will include completion, EMI engagement, and acceptability as measures of intervention feasibility, and screening, eligibility, enrollment, and retention rates as measures of trial feasibility. Primary outcomes will be evaluated against a priori benchmarks. Secondary outcomes will include counselor adherence to motivational interviewing principles, therapeutic alliance, duration of study activities, barriers, facilitators, CUD symptoms, and amount of delta-9-tetrahydrocannabinol used in standard units for motivation to change cannabis use, psychological distress, cognitive function, and quality of life. We will also examine cannabis use frequency and problems resulting from cannabis use. For the quantitative analyses, we will use descriptive statistics, logistic regression, and generalized linear mixed effects modeling. For the qualitative analyses, we will use immersion/crystallization, template organizing style, and thematic analysis.

Results

Recruitment began in August 2025 and is anticipated to end in January 2027. Data collection is projected to be completed in July 2027. We plan to submit a manuscript describing the main outcomes in early 2028.

Conclusions

This study will provide data regarding the MOMENT-V digital health intervention and trial feasibility in anticipation of a fully powered efficacy trial in young adults with CUD who are being seen in primary care.

Subjects

MeSH terms (MEDLINE)

Marijuana AbuseHumansPilot ProjectsTelemedicineYoung AdultAdolescentRandomized Controlled Trials as TopicFemaleAdultMaleDigital HealthMotivational InterviewingMotivation

Author keywords

behavior-change interventioncannabis-related disorderecological momentary assessmentmHealthmobile healthmotivational interviewingtelehealthyoung adults

Authors and institutions

  • Department of Pediatrics, Harvard Medical School, Boston, MA, United States.
  • Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, United States, 1 617-355-8306, 1 617-730-0004.
  • Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, MA, United States.
  • Department of Anesthesia, Harvard Medical School, Boston, MA, United States.
  • Division of Sleep Medicine, Harvard Medical School, Boston, MA, United States.
  • Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, United States.

ORCID profiles: Lydia A Shrier, Avery Palmer, Joe Kossowsky, Sabra L Katz-Wise, Pamela J Burke, Carly E Milliren, Sion Kim Harris

Funding

  • NIDA NIH HHS

Cite

APA

Shrier, L. A., Palmer, A., Parker, S., Kossowsky, J., Katz-Wise, S. L., Burke, P. J., Milliren, C. E., & Harris, S. K. (2026). Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols, 15, e105908-e105908. https://doi.org/10.2196/105908

Vancouver

Shrier LA, Palmer A, Parker S, Kossowsky J, Katz-Wise SL, Burke PJ, et al. Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e105908-e105908. doi:10.2196/105908

BibTeX
@article{Shrier2026,
  author = {Shrier, Lydia A and Palmer, Avery and Parker, Sarah and Kossowsky, Joe and Katz-Wise, Sabra L and Burke, Pamela J and Milliren, Carly E and Harris, Sion Kim},
  title = {Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e105908--e105908},
  doi = {10.2196/105908}
}
Start for free →